Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011 (2011), Article ID 254914, 7 pages
http://dx.doi.org/10.1155/2011/254914
Research Article

Caffeoylquinic Acids Are Major Constituents with Potent Anti-Influenza Effects in Brazilian Green Propolis Water Extract

1Nagaragawa Research Center, API Co., Ltd., 692-3 Nagara, Yamasaki, Gifu 502-0071, Japan
2United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan
3CREST, Japan Science and Technology Agency, 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, Japan
4Center for Emerging Infectious Diseases, Gifu University, 1-1 Yanagido, Gifu 501-1194, Japan

Received 18 November 2010; Revised 27 December 2010; Accepted 9 January 2011

Copyright © 2011 Tomohiko Urushisaki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. T. Wang and P. Palese, “Unraveling the mystery of swine influenza virus,” Cell, vol. 137, no. 6, pp. 983–985, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. E. de Clercq, “Antiviral agents active against influenza A viruses,” Nature Reviews Drug Discovery, vol. 5, no. 12, pp. 1015–1025, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. S. P. Layne, A. S. Monto, and J. K. Taubenberger, “Pandemic influenza: an inconvenient mutation,” Science, vol. 323, no. 5921, pp. 1560–1561, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Kiso, K. Takahashi, Y. Sakai-Tagawa et al., “T-705 (favipiravir) activity against lethal H5N1 influenza A viruses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 2, pp. 882–887, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. G. A. Burdock, “Review of the biological properties and toxicity of bee propolis (propolis),” Food and Chemical Toxicology, vol. 36, no. 4, pp. 347–363, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. A. H. Banskota, Y. Tezuka, and S. Kadota, “Recent progress in pharmacological research of propolis,” Phytotherapy Research, vol. 15, no. 7, pp. 561–571, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. E. F. Mohamed and A. A. Owayss, “An inhibitory activity of propolis extract against BroadBean Mottle Bromovirus (BBMV),” International Journal of Virology, vol. 1, article 31, 2005. View at Google Scholar
  8. M. Amoros, C. M. O. Simoes, L. Girre, F. Sauvager, and M. Cormier, “Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis,” Journal of Natural Products, vol. 55, no. 12, pp. 1732–1740, 1992. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Amoros, E. Lurton, J. Boustie, L. Girre, F. Sauvager, and M. Cormier, “Comparison of the anti-herpes simplex virus activities of propolis and 3- methyl-but-2-enyl caffeate,” Journal of Natural Products, vol. 57, no. 5, pp. 644–647, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Huleihel and V. Isanu, “Anti-herpes simplex virus effect of an aqueous extract of propolis,” Israel Medical Association Journal, vol. 4, no. 11, pp. 923–927, 2002. View at Google Scholar · View at Scopus
  11. S. Nolkemper, J. Reichling, K. H. Sensch, and P. Schnitzler, “Mechanism of herpes simplex virus type 2 suppression by propolis extracts,” Phytomedicine, vol. 17, no. 2, pp. 132–138, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Schnitzler, A. Neuner, S. Nolkemper et al., “Antiviral activity and mode of action of propolis extracts and selected compounds,” Phytotherapy Research, vol. 24, no. 1, pp. S20–S28, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. C. Búfalo, A. S. Figueiredo, J. P. B. de Sousa, J. M. G. Candeias, J. K. Bastos, and J. M. Sforcin, “Anti-poliovirus activity of Baccharis dracunculifolia and propolis by cell viability determination and real-time PCR,” Journal of Applied Microbiology, vol. 107, no. 5, pp. 1669–1680, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. F. K. Abd El Hady and A. G. Hegazi, “Egyptian propolis: 2. Chemical composition, antiviral and antimicrobial activities of East Nile Delta propolis,” Zeitschrift fur Naturforschung C, vol. 57, no. 3-4, pp. 386–394, 2002. View at Google Scholar · View at Scopus
  15. Z. Harish, A. Rubinstein, M. Golodner, M. Elmaliah, and Y. Mizrachi, “Suppression of HIV-1 replication by propolis and its immunoregulatory effect,” Drugs under Experimental and Clinical Research, vol. 23, no. 2, pp. 89–96, 1997. View at Google Scholar · View at Scopus
  16. J. Ito, F. R. Chang, H. K. Wang et al., “Anti-AIDS agents. 48. Anti-HIV activity of moronic acid derivatives and the new melliferone-related triterpenoid isolated from Brazilian propolis,” Journal of Natural Products, vol. 64, no. 10, pp. 1278–1281, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Gekker, S. Hu, M. Spivak, J. R. Lokensgard, and P. K. Peterson, “Anti-HIV-1 activity of propolis in CD4 lymphocyte and microglial cell cultures,” Journal of Ethnopharmacology, vol. 102, no. 2, pp. 158–163, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Bankova, M. C. Marcucci, S. Simova, N. Nikolova, A. Kujumgiev, and S. Popov, “Antibacterial diterpenic acids from Brazilian propolis,” Zeitschrift fur Naturforschung C, vol. 51, no. 5-6, pp. 277–280, 1996. View at Google Scholar · View at Scopus
  19. V. Maksimova-Todorova, N. Manolova, G. Gegova, Iu. Serkedzhieva, and S. Uzunov, “Antiviral effects of some fractions isolated from propolis,” Acta Microbiologica Bulgarica, vol. 17, pp. 79–85, 1985. View at Google Scholar
  20. M. Amoros, F. Sauvager, L. Girre, and M. Cormier, “Invitro antiviral activity of propolis,” Apidologie, vol. 23, pp. 231–240, 1992. View at Google Scholar
  21. J. Serkedjieva, N. Manolova, and V. Bankova, “Anti-influenza virus effect of some propolis constituents and their analogues (esters of substituted cinnamic acids),” Journal of Natural Products, vol. 55, no. 3, pp. 294–297, 1992. View at Google Scholar · View at Scopus
  22. V. Esanu, E. Prahoveanu, J. Crisan, and A. Cioca, “The effect of an aqueous propolis extract, of rutin and of a rutin-quercetin mixture on experimental influenza virus infection in mice,” Virologie, vol. 32, no. 3, pp. 213–215, 1981. View at Google Scholar · View at Scopus
  23. H. Neychev, V. Dimov, V. Vuleva et al., “Immunomodulatory action of propolis. II. Effect of water-soluble fraction on influenza infection in mice,” Acta Microbiologica Bulgarica, vol. 23, pp. 58–62, 1988. View at Google Scholar · View at Scopus
  24. T. Shimizu, A. Hino, A. Tsutsumi, K. P. Yong, W. Watanabe, and M. Kurokawa, “Anti-influenza virus activity of propolis in vitro and its efficacy against influenza infection in mice,” Antiviral Chemistry and Chemotherapy, vol. 19, no. 1, pp. 7–13, 2008. View at Google Scholar · View at Scopus
  25. S. Kumazawa, M. Yoneda, and T. Nakayama, “Constituents in Brazilian propolis and its plant of origin,” Foods and Food Ingredients Journal of Japan, vol. 209, pp. 132–139, 2004. View at Google Scholar
  26. V. Bankova, “Recent trends and important developments in propolis research,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 1, pp. 29–32, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Mishima, C. Yoshida, S. Akino, and T. Sakamoto, “Antihypertensive effects of Brazilian propolis: identification of caffeoylquinic acids as constituents involved in the hypotension in spontaneously hypertensive rats,” Biological and Pharmaceutical Bulletin, vol. 28, no. 10, pp. 1909–1914, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Tominaga, M. Ishiyama, F. Ohseto et al., “A water-soluble tetrazolium salt useful for colorimetric cell viability assay,” Analytical Communications, vol. 36, no. 2, pp. 47–50, 1999. View at Google Scholar · View at Scopus
  29. H. Izuta, Y. Narahara, M. Shimazawa, S. Mishima, S. I. Kondo, and H. Hara, “1,1-diphenyl-2-picrylhydrazyl radical scavenging activity of bee products and their constituents determined by ESR,” Biological and Pharmaceutical Bulletin, vol. 32, no. 12, pp. 1947–1951, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Aga, T. Shibuya, H. Chaen, S. Fukuda, and M. Kurimoto, “Stabilization by trehalose of superoxide dismutase-like activity of various vegetables,” Journal of the Japanese Society for Food Science and Technology, vol. 45, pp. 210–215, 1998. View at Google Scholar
  31. J. Focht, S. H. Hansen, J. V. Nielsen, A. van den Berg-Segers, and R. Riezler, “Bactericidal effect of propolis in vitro against agents causing upper respiratory tract infections,” Arzneimittel-Forschung, vol. 43, no. 8, pp. 921–923, 1993. View at Google Scholar · View at Scopus
  32. V. Bankova, R. Christov, A. Kujumgiev, M. C. Marcucci, and S. Popov, “Chemical composition and antibacterial activity of Brazilian propolis,” Zeitschrift fur Naturforschung C, vol. 50, no. 3-4, pp. 167–172, 1995. View at Google Scholar · View at Scopus
  33. B. Bingol, C. F. Wang, D. Arnott, D. Cheng, J. Peng, and M. Sheng, “Autophosphorylated CaMKIIα acts as a scaffold to recruit proteasomes to dendritic spines,” Cell, vol. 140, no. 4, pp. 567–578, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. W. Tu, X. Xu, L. Peng et al., “DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke,” Cell, vol. 140, no. 2, pp. 222–234, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Dong, Q. Yang, Q. Wang et al., “Elevated ATPase activity of KaiC applies a circadian checkpoint on cell division in Synechococcus elongatus,” Cell, vol. 140, no. 4, pp. 529–539, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. A. K. Tehranchi, M. D. Blankschien, Y. Zhang et al., “The transcription factor DksA prevents conflicts between DNA replication and transcription machinery,” Cell, vol. 141, no. 4, pp. 595–605, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Kujumgiev, I. Tsvetkova, Y. Serkedjieva, V. Bankova, R. Christov, and S. Popov, “Antibacterial, antifungal and antiviral activity of propolis of different geographic origin,” Journal of Ethnopharmacology, vol. 64, no. 3, pp. 235–240, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Drago, E. de Vecchi, L. Nicola, and M. R. Gismondo, “In vitro antimicrobial activity of a novel propolis formulation (Actichelated propolis),” Journal of Applied Microbiology, vol. 103, no. 5, pp. 1914–1921, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. V. Maksimova-Todorova, N. Manolova, G. Gegova, I. Serkedzhieva, and S. Uzunov, “Antiviral action of fractions isolated from propolis,” Acta Microbiologica Bulgarica, vol. 17, pp. 79–85, 1985. View at Google Scholar
  40. V. Esanu, “Research in the field of antiviral chemotherapy performed in the "Stefan S. Nicolau" Institute of Virology,” Virologie, vol. 35, no. 4, pp. 281–293, 1984. View at Google Scholar · View at Scopus
  41. S. Kumazawa, S. Tazawa, T. Noro, and T. Nakayama, “Analysis of propolis by liquid-chromatography-mass spectrometry,” Honeybee Science, vol. 21, pp. 164–168, 2000. View at Google Scholar
  42. S. Shi, K. Huang, Y. Zhang, Y. Zhao, and Q. Du, “Purification and identification of antiviral components from Laggera pterodonta by high-speed counter-current chromatography,” Journal of Chromatography B, vol. 859, no. 1, pp. 119–124, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Huleihel and V. Ishano, “Effect of propolis extract on malignant cell transformation by Moloney murine sarcoma virus,” Archives of Virology, vol. 146, no. 8, pp. 1517–1526, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Li, P. P. H. But, and V. E. C. Ooi, “Antiviral activity and mode of action of caffeoylquinic acids from Schefflera heptaphylla (L.) Frodin,” Antiviral Research, vol. 68, no. 1, pp. 1–9, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. W. Pluymers, N. Neamati, C. Pannecouque et al., “Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters,” Molecular Pharmacology, vol. 58, no. 3, pp. 641–648, 2000. View at Google Scholar · View at Scopus
  46. K. Andries, M. Moeremans, T. Gevers et al., “Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus,” Antiviral Research, vol. 60, no. 3, pp. 209–219, 2003. View at Publisher · View at Google Scholar · View at Scopus